Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age29-18
SponsorChildren's Hospital of Fudan University
About this trial
Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly identified in children in China. Pediatric intensive care unit (PICU) is the high-risk area. However, data on the epidemiology of CRE in hospitalized children in PICU are limited. The objectives of this study are to characterize the risk factors for colonization or infection with CRE and describe the microbiologic characteristics of pediatric CRE isolates. The investigators will perform a single retrospective study from January 2018 to December 2019 at PICU of Children's Hospital of Fudan University .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All children hospitalized in PICU of Children's Hospital of Fudan University from January 2018 to December 2019.
Disqualifiers
discharge within 48 hours
patients had a positive culture for CRE before admission
incomplete clinical and demographic data
Trial population
All children hospitalized in PICU of Children's Hospital of Fudan University from January 2018 to December 2019
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
536 Participants
are grouped into 3 trial groupsGroup A: non CRE
Group B: CRE colonization
Group C: CRE infection
Trial outcomes
Primary outcomes
1
mortality
The death rate of children in 28 days after their discharged from PICU
Time frame
within 28 days after they discharged from PICUSecondary outcomes
1
length of stay in PICU
Time from PICU admission to discharge
Time frame
within 28 days after they discharged from PICUSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov